# Elizabeth Garrett‐Mayer

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/elizabeth-garrett-mayer/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,906 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 70 |
| i10-index | 241 |
| Last Known Institution | American Society of Clinical Oncology |
| OpenAlex ID | https://openalex.org/A5029296725 |
| ORCID iD | https://orcid.org/0000-0003-4709-0333 |
| Works | 576 |

## Researcher papers

- [Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy](https://scholariq.org/papers/increased-circulating-myeloid-derived-suppressor-cells-correlate-with-clinical/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Statistical Methods in Clinical Trials](https://scholariq.org/topics/statistical-methods-in-clinical-trials/)

## Researcher university

- [American Society of Clinical Oncology](https://scholariq.org/institutions/american-society-of-clinical-oncology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.